General Information of the Compound
Compound ID
CP0505152
Compound Name
(2S)-2-methyl-1-[2-(4-methylphenyl)ethyl]pyrrolidine
    Show/Hide
Synonyms
(S)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine
CHEMBL257911
    Show/Hide
Structure
Formula
C14H21N
Molecular Weight
203.329
Canonical SMILES
C[C@H]1CCCN1CCc1ccc(C)cc1
    Show/Hide
InChI
InChI=1S/C14H21N/c1-12-5-7-14(8-6-12)9-11-15-10-3-4-13(15)2/h5-8,13H,3-4,9-11H2,1-2H3/t13-/m0/s1
    Show/Hide
InChIKey
BFMXEUSPYLVDSY-ZDUSSCGKSA-N
Physicochemical Property
logP
3.02182
Rotatable Bonds
3
Heavy Atom Count
15
Polar Areas
3.24
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
1
Complexity
15

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44456126
ChEMBL ID
CHEMBL257911
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01194, Histamine H3 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 27 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( (S)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine )
Drug Name (S)-2-methyl-1-(2-p-tolyl-ethyl)-pyrrolidine
Target(s)
Histamine H3 receptor (H3R)
Inhibitor